Novel CAR T cell therapy obe-cel demonstrates high response rates in adult patients with advanced B-cell ALL
Patients with relapsed or refractory CD19-positive B-cell acute lymphoblastic leukemia (ALL) who were treated with the novel anti-CD19 chimeric antigen receptor (CAR) T cell therapy, obecabtagene autoleucel (obe-cel), experienced high response rates and most did not need a subsequent stem cell transplant (SCT), according to results from the Phase Ib/II FELIX trial co-led by researchers at Â鶹ӳ» MD Anderson Cancer Center...
MD Anderson, the Oden Institute and TACC announce funding for six new collaborative cancer projects
Â鶹ӳ» MD Anderson Cancer Center, the Oden Institute for Computational Engineering and Sciences and the Texas Advanced Computing...
Energy Transfer and Sunoco donate $2 million to support pediatric cancer research at MD Anderson
HOUSTON ¨D Â鶹ӳ» MD Anderson Cancer Center today announced a $2?million donation from Dallas-based Energy Transfer as...
MD Anderson Research Highlights for November 21, 2024
Â鶹ӳ» MD Anderson Cancer Center¡¯s Research Highlights showcases the latest breakthroughs in cancer care, research and prevention. These advances are made possible through seamless collaboration between MD Anderson¡¯s world-leading clinicians and scientists, bringing discoveries from the lab to the clinic and back.
Modified drug reverses chronic pain with reduced side effects
Oxidative stress, which can cause...
MD Anderson receives nearly $8 million in CPRIT funding for screening and early detection programs, faculty recruitment
Â鶹ӳ» MD Anderson Cancer Center today was awarded nearly $8 million from the Cancer Prevention and Research Institute of...
Healthy women have cells that resemble breast cancer, study finds
A new study from researchers at Â鶹ӳ» MD Anderson Cancer Center finds that, in healthy women, some breast cells that otherwise...
MD Anderson Research Highlights: SITC 2024 Special Edition
Â鶹ӳ» MD Anderson Cancer Center¡¯s Research Highlights showcases the latest breakthroughs in cancer care, research and prevention...
MD Anderson launches Institute for Cell Therapy Discovery & Innovation to deliver transformational new therapies
Â鶹ӳ» MD Anderson Cancer Center today announced the launch of its Institute for Cell Therapy Discovery & Innovation,...
Brown Foundation Award for Excellence in Oncology Nursing honors Tiffany Richards
HOUSTON ¨D?Â鶹ӳ» MD Anderson Cancer Center today honored Tiffany Richards, Ph.D., A.P.R.N., A.N.P.-B.C., A.O.C.N.P., with...
MD Anderson¡¯s Boot Walk to End Cancer? raises $1.4 million
HOUSTON ¨D Â鶹ӳ» MD Anderson Cancer Center hosted its ninth annual Boot Walk to End Cancer? fundraising event on Saturday...
Jennifer Bickel, M.D., named MD Anderson Vice President and Chief Wellness Officer
Â鶹ӳ» MD Anderson Cancer Center today announced the selection of Jennifer Bickel, M.D., as the institution¡¯s inaugural vice...
MD Anderson Board of Visitors celebrates growth and achievement
HOUSTON ¨D Â鶹ӳ» MD Anderson Cancer Center started its fiscal year on a celebratory note by welcoming seven new members to...
Michael Frumovitz, M.D., posthumously honored with Julie and Ben Rogers Award for Excellence
HOUSTON ¨D Â鶹ӳ» MD Anderson Cancer Center has posthumously awarded Michael Frumovitz, M.D., with the Julie and Ben Rogers...